-
This recently published Cochrane review examines the effects of a class of treatments on people with COVID-19.
Treating COVID-19 with tocilizumab (a medicine that blocks interleukin-6) reduces the numbers of people who die within 28 days of treatment, and probably results in fewer serious unwanted effects than placebo treatment.
Studies of other...
18 marzo 2021
-
17 marzo 2021
-
15 marzo 2021
-
15 marzo 2021
-
15 marzo 2021
-
11 marzo 2021
-
In this short interview, Prof. John GF Cleland, senior author of this recently published Cochrane review, tells us about what this review found regarding the type of heart and blood vessel problems that complicate COVID-19 infections.
Tell us about this review.
This review first focuses on cardiovascular problems pre-existing the development of...
11 marzo 2021
-
Evidence published in the Cochrane Library today will reassure people who want to stop smoking that quitting for at least 6 weeks may improve their mental wellbeing, by reducing anxiety, depression, and stress. People’s social relationships are unlikely to suffer if they stop smoking.
Smoking is the world's leading cause of preventable illness...
9 marzo 2021
-
8 marzo 2021
-
2 marzo 2021